Stocks360

Aurora Spine Corporation (ASAPF)

Stock analysis · OTC · Healthcare · Medical - Devices

Share: Facebook X WhatsApp SMS
$0.08

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
$6.36M
PE (TTM)
-5.58
EPS (TTM)
N/A
Dividend Yield
0.00%
Beta
-0.56
Day Range
$0.08 – $0.10
52-wk Range
$0.07 – $0.24
Avg Volume
N/A
Volume
12.00K

Aurora Spine Corporation (ASAPF) is a publicly traded company in the Healthcare sector. Latest price: $0.08. Market cap $6.36M. Trailing PE -5.58. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-30 · $0.23 2026-10-28 · $0.08 (-64.57%)

Earnings

Next Earnings
Nov 16, 2026
EPS estimate $0.00

Proprietary Signals

Signal snapshot temporarily unavailable.

About Aurora Spine Corporation

Aurora Spine Corporation, operating through its subsidiary Aurora Spine, Inc., specializes in the development and distribution of advanced, minimally invasive spine fusion systems and related medical devices. The company's diverse product portfolio includes a range of interspinous process lumbar fusion devices, such as the ZIP, ZIP ULTRA, ZIP LP, and ZIP-51 lines, specifically engineered to treat patients suffering from degenerative disc diseases. Additionally, Aurora Spine provides titanium-coated polyether ether ketone (PEEK) interbody cages. These cages are crucial for maintaining proper spacing and stability between spinal vertebrae, thereby encouraging bone growth to achieve successful fusion. Aurora Spine also supplies sterile, titanium plasma spray coated spinal implants designed to promote bone integration. Complementing these, it offers a suite of interbody products such as the EOS, VOX, Echo, Echo SD, and EchoXL series for lumbar applications, and the Discovery system for cervical surgeries. Among its innovations is SOLO, a 3D-printed, stand-alone anterior lumbar interbody fusion device. This integrated plate and spacer system is designed to maintain the spine's natural…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)-5.58×
P/S (TTM)0.39×
P/B2.38×
PEG0.05×
P/FCF (TTM)21.76×
EV / EBITDA38.36×
EV / Sales0.49×
Earnings Yield-18.01%
Free Cash Flow Yield4.60%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value$8.51M
Revenue (TTM)$17.38M
Net Income (TTM)-$1.21M
Free Cash Flow (TTM)$643.49K
Net Debt$1.80M
Working Capital$3.66M
Gross Margin41.85%
Operating Margin-4.98%
Net Margin-6.95%
Return on Equity-34.32%
Return on Invested Capital-13.75%

Peers

Recent News

Related

Browse more tickers: sitemap